Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parkin interacts with the proteasome subunit alpha4.

J C Dächsel1, C B Lücking, S Deeg

  • 1Labor für Molekulare Neurogenetik, Neurologische Klinik der Ludwig-Maximilians-Universität, Marchioninistr. 15, 81377 München, Germany.

FEBS Letters
|July 1, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic variation and pesticide exposure influence blood DNA methylation signatures in females with early-stage Parkinson's disease.

NPJ Parkinson's disease·2024
Same author

The PINK1 kinase-driven ubiquitin ligase Parkin promotes mitochondrial protein import through the presequence pathway in living cells.

Scientific reports·2019
Same author

The genetic landscape of Parkinson's disease.

Revue neurologique·2018
Same author

Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein.

Scientific reports·2017
Same author

The Autosomal Recessive Form of CMT Disease Linked to 5q31-q33.

Annals of the New York Academy of Sciences·2017
Same author

The Autosomal Recessive Form of CMT Disease Linked to 5q31-q33.

Annals of the New York Academy of Sciences·2017

Researchers identified alpha4, a proteasome subunit, as a new parkin interacting partner. This discovery sheds light on the molecular mechanisms of parkin-related Parkinson's disease and proteasome regulation.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Mutations in the parkin gene cause autosomal recessive Parkinson's disease.
  • The precise molecular mechanisms of parkin-related neurodegeneration remain unclear.
  • Parkin is an E3 ubiquitin ligase involved in protein degradation.

Purpose of the Study:

  • To identify novel interacting partners of parkin.
  • To elucidate the role of parkin in the context of proteasome function.
  • To investigate the molecular basis of parkin-mediated neurodegeneration.

Main Methods:

  • Co-immunoprecipitation to identify interacting proteins.
  • Biochemical assays to study ubiquitylation and proteasomal activity.
  • Cell-based assays using HEK 293T cells.

Related Experiment Videos

Main Results:

  • The 20S proteasomal subunit alpha4 (PSMA7) was identified as a novel parkin interacting partner.
  • The interaction requires the C-terminal IBR-RING domain of parkin and the C-terminal region of alpha4.
  • Alpha4 is not a direct substrate for parkin-dependent ubiquitylation.
  • Parkin expression, particularly full-length or lacking the N-terminal ubiquitin-like domain, slightly enhanced proteasomal activity.

Conclusions:

  • Parkin interacts with the 20S proteasome subunit alpha4, suggesting a role in substrate presentation or proteasome regulation.
  • The findings provide new insights into the molecular mechanisms of Parkinson's disease pathogenesis.
  • This interaction may represent a novel regulatory mechanism for proteasome function by parkin.